Hoth Cash from 2010 to 2025

HOTH Stock  USD 0.92  0.01  1.10%   
Hoth Therapeutics' Cash is increasing with slightly volatile movements from year to year. Cash is estimated to finish at about 11.2 M this year. Cash is the total amount of money in the form of currency that Hoth Therapeutics has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2017-12-31
Previous Quarter
9.7 M
Current Value
M
Quarterly Volatility
5.1 M
 
Covid
Check Hoth Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hoth Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 668, Interest Expense of 368.8 K or Selling General Administrative of 4.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.61. Hoth financial statements analysis is a perfect complement when working with Hoth Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Hoth Therapeutics Correlation against competitors.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

Latest Hoth Therapeutics' Cash Growth Pattern

Below is the plot of the Cash of Hoth Therapeutics over the last few years. Cash refers to the most liquid asset of Hoth Therapeutics, which is listed under current asset account on Hoth Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Hoth Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Hoth Therapeutics account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Hoth Therapeutics' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hoth Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Hoth Cash Regression Statistics

Arithmetic Mean3,788,289
Geometric Mean2,240,703
Coefficient Of Variation104.04
Mean Deviation3,403,063
Median1,230,440
Standard Deviation3,941,401
Sample Variance15.5T
Range10.9M
R-Value0.83
Mean Square Error5.2T
R-Squared0.69
Significance0.000071
Slope686,507
Total Sum of Squares233T

Hoth Cash History

202511.2 M
202410.7 M
20239.3 M
20226.4 M
20218.5 M
20202.6 M
20191.7 M

Other Fundumenentals of Hoth Therapeutics

Hoth Therapeutics Cash component correlations

About Hoth Therapeutics Financial Statements

Investors use fundamental indicators, such as Hoth Therapeutics' Cash, to determine how well the company is positioned to perform in the future. Although Hoth Therapeutics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

Currently Active Assets on Macroaxis

When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:
Check out the analysis of Hoth Therapeutics Correlation against competitors.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Return On Assets
(0.46)
Return On Equity
(0.83)
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.